Intuitive Surgical, Inc. vs Royal Caribbean Cruises Ltd — how do they compare? Intuitive Surgical, Inc. trades at $423.96 (market cap $146.76B), while Royal Caribbean Cruises Ltd trades at $282.26 (market cap $75.26B). The key difference: Intuitive Surgical, Inc. is the larger of the two by market cap, and Royal Caribbean Cruises Ltd pays a 2.13% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Intuitive Surgical, Inc. for 84 Days and Royal Caribbean Cruises Ltd for 85 Days on average.
| ISRG | RCL | |
|---|---|---|
Market Cap | $146.76B | $75.26B |
Volume | 2,529,814 | 1,958,628 |
Sector | Health | Consumer Cyclical |
52-Week High | $592.85 | $348.03 |
52-Week Low | $332.02 | $230.30 |
Typical Hold Time | 84 Days | 85 Days |
Enterprise Value | $141.54B | $97.91B |
Dividend Yield | — | 2.13% |
Signals from Pluang's Aura AI — not financial advice
Intuitive Surgical (ISRG) trades at $415.41, up 0.21% today, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.80, and has shown consistent revenue growth, reaching $10.06B in 2025. Analyst consensus is strongly bullish with a $480.78 price target, though the stock faces headwinds from slower procedure growth in some markets.
The outlook for ISRG remains positive due to its dominant position in robotic surgery, expanding international presence, and high recurring revenue. Key risks include competitive pressures, regulatory hurdles, and economic sensitivity affecting procedure volumes. With solid fundamentals and analyst support, the stock offers growth potential, but investors should monitor execution against these risks.
Royal Caribbean (RCL) trades at $281.39, showing modest daily weakness but maintaining strong bullish momentum with analyst consensus pointing to significant upside. The company demonstrates robust fundamentals with revenue growth from $8.8B in 2022 to $17.9B in 2025, net income margin expanding to 23.54%, and positive cash flow generation. Recent developments include a $3B investment in Sandals Resorts and strong Q2 2026 earnings beat, while technical indicators show the stock trading near key resistance levels with overall bullish signals.
RCL presents compelling investment potential with 23% upside to consensus price target of $346.67, supported by strong earnings momentum and expanding profitability. However, risks include elevated debt levels, execution challenges from the Sandals acquisition, and sensitivity to fuel price volatility. The stock's current valuation at 17.38x P/E appears reasonable given the company's growth trajectory and industry-leading margins.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →Royal Caribbean is the world's second-largest cruise company, operating 64 ships across five global and partner brands in the cruise vacation industry, with 10 more ships on order. Brands the company operates include Royal Caribbean International, Celebrity Cruises, and Silversea. The company also has a 50% investment in a joint venture that operates TUI Cruises and Hapag-Lloyd Cruises, allowing it to compete on the basis of innovation, quality of ships and service, variety of itineraries, choice of destinations, and price. The company completed the divestiture of its Azamara brand in the first quarter of 2021.
Read more on RCL →